Arthritis Pain Treatment

Glucosamine, Chondroitin Did Not Slow Knee Damage In Osteoarthritis Treatment

2008-09-30 01:39

New research was reported in the journal Arthritis and Rheumatism that shows glucosamine and chondroitin for arthritis treatment are no better than placebo in slowing the loss of knee cartilage. The two-year study showed that the popular over the counter supplements did not work better than sugar pills.

Six New Genetic Indicators For Rheumatoid Arthritis

2008-09-23 08:05

Researchers from Brigham and Women’s Hospital (BWH) and colleagues have uncovered specific locations on chromosomes (loci) linked to rheumatoid arthritis (RA), a progressive autoimmune disease that attacks the joints and other organs. Variations in the genetic sequence at these locations imply a risk of developing RA.

Arthroscopy For Knee Arthritis Treatment Doesn't Work

2008-09-15 00:32

A new study in the New England Journal of Medicine shows that arthroscopic surgery with debridement to "clean up" an arthritic knee was of no more benefit than Advil or Tylenol and physical therapy in men and women with osteoarthritis. The same findings were reported in 2002 in a large study done by the Department of Veterans Affairs, but orthopedic surgeons have continued performing the surgery as a treatment for chronic knee pain in patients with osteoarthritis.

Osteoarthritis Patients Don't Benefit From Arthroscopic Surgery

2008-09-11 09:59

Osteoarthritis patients do not really benefit from arthroscopic surgery, which is a common treatment method for knee patients.

Knee patients suffering from osteoarthritis usually experience pain and weakened joint function. They are being treated by physical therapy, medication, and arthroscopic surgery. This surgery is not very invasive - a small arthroscope (long, thin, fiberoptic tube) and a few other instruments are being inserted into the joint. The instruments remove cartilage fragments and make joint surfaces smoother. The surgery is easy to perform and is widely acceptable.

New Guidelines For Rheumatoid Arthritis Treatment

2008-07-23 10:33

Updated rules add new arthritis drugs and combinations for treatment. However, these recommendations for rheumatoid arthritis treatment are not meant to override individualized care.

Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham (UAB).

Health Canada Advises Not To Use Homoeopathy Arthrit Indica Tablet

2008-07-02 13:04

Health Canada is advising consumers not to use 3rd Generation In Homoeopathy Arthrit Indica Tablet due to concerns about possible side-effects.

Product label promotes use for "intense joint pain."

Arthrit Indica Tablets contain nimesulide, a pharmaceutical ingredient that is not authorized for sale in Canada. Nimesulide has been withdrawn from the market in several countries due to an association with liver damage.

Possible Side-Effects

Use of nimesulide has been associated with liver damage.

Golimumab Effective In Patients With Active Rheumatoid Arthritis

2008-06-13 10:58

Patients with moderately-to-severely active rheumatoid arthritis who were previously treated with anti-tumor necrosis factor-alpha agents, experienced significant improvements in signs and symptoms and physical function after receiving every four-week subcutaneous injections of golimumab.

Staying Active Best Way To Control Arthritis Pain

2008-05-28 10:33

Arthritis affects one in every four adults in Wisconsin, and nationally it is the most common cause of disability. Yet state health officials report that if arthritis sufferers exercise for short periods of time, despite their discomfort, they can come one step closer to relieving some of their aches and pains.

Trubion Initiates Study Of SBI-087 For Rheumatoid Arthritis Treatment

2008-04-24 10:20

Wyeth Pharmaceuticals has initiated a Phase 1 clinical trial of SBI-087, a next-generation drug candidate for the treatment of rheumatoid arthritis (RA). In collaboration with Trubion, Wyeth Pharmaceuticals is developing SBI-087 and other CD20-directed products. SBI-087 for RA builds on Trubion and Wyeth's clinical experience with Trubion's lead compound, TRU-015, and is based on Trubion's Small Modular ImmunoPharmaceutical (SMIP) technology.

Pine Bark Naturally Reduces Osteoarthritis

2008-04-18 11:29

More than 20 million Americans suffer from osteoarthritis, with half a million Americans having a total joint replacement each year. A new study to be published in the April 2008 edition (Volume 22, issue No 4) of the journal of Phytotherapy Research shows Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, was shown to reduce all osteoarthritis symptoms by 56 percent. The study revealed a particularly high efficacy of Pycnogenol for lowering joint pain by 55 percent.